Community-based weight loss program for heart health in Washington D.C.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to develop a community-based behavioral weight loss intervention to improve heart health among African-American adults in Washington D.C. Researchers will collaborate with local church leaders to assess health needs and factors affecting cardiovascular health, such as diabetes, blood pressure, and cholesterol levels. Participants will undergo health screenings at their churches, including measurements of body mass index (BMI) and blood samples. The findings will inform future interventions tailored to the specific needs of this community.

Why it matters

Who can join: the full rules

* INCLUSION CRITERIA:

Individuals eligible for this protocol are aged 19 - 85 years, have attended or visited any church or faith-based organization in DC, Maryland, or Virginia, and are able to provide informed consent independently. Eligible participants should also speak and read English at the 8th grade level.

EXCLUSION CRITERIA:

Women in their second or third trimester of pregnancy at the time of enrollment will be excluded from the protocol.

Where it's running

• National Institutes of Health Clinical Center
  Bethesda, Maryland, United States Recruiting

Study contacts

• Principal investigator: Tiffany M Powell-Wiley, M.D. — National Heart, Lung, and Blood Institute (NHLBI)
• Study coordinator: Marie Marah, R.N.
• Email: marie.marah@nih.gov
• Phone: (301) 640-1701

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Clazakizumab for adults with high hsCRP at risk for a heart event

  This study tests whether clazakizumab can lower inflammation and reduce cardiovascular risk in adults with high hsCRP and existing risk factors.

  Recruiting at 32 sites Phase 2 Eli Lilly and Company · Huntsville, Alabama and 45 other locations · NCT07783802

• Digital tool for doctors to prescribe exercise for people with cardiovascular risk factors

  This project will test whether a new digital tool helps doctors create personalized exercise plans for adults with cardiovascular risk factors.

  Recruiting at 2 sites University of Connecticut · Farmington, Connecticut and 2 other locations · NCT07238556

• Registry studying obesity, circadian rhythm, and aging

  This study is trying to see how obesity, sleep patterns, and aging are connected by following 2,000 adults over 10 years to learn more about their health.

  Recruiting Chang Gung Memorial Hospital · Taoyuan · NCT02674230

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.